Example dataset comparing two antibody responses against the first 35 sequences. Both antibodies interact strongly with WT RBD peptide #9 (RP9) and lose affinity when the K417N (Beta & Omicron) or K417T (Gamma) mutations are present.
SARS-CoV-2 RBD Peptide and Glycopeptide Array
Z Biotech’s SARS-CoV-2 Receptor-Binding Domain (RBD) Peptide and Glycopeptide Array allows researchers to identify, profile, and compare specific IgG, IgA, and IgM antibody responses or detect and validate protein interactions with various RBD sequences in a customizable format.
Researchers can choose from a list of 83 15-mer WT and mutant RBD peptide sequences, including sequences from the Alpha, Beta, Gamma, Delta, Omicron, and other SARS-CoV-2 variants. Four glycopeptides have been added to the list. The selected sequences are immobilized on a glass slide using our proprietary multivalent surface coating technology, which minimizes background and maximizes sensitivity.
List of peptides and glycopeptides for custom microarrays; additional peptides and glycopeptides available upon request.